Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-31

Clinical Trial Update: LIROH - Liraglutide for Obesity in HIV [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating liraglutide for obesity in people with HIV and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obesity, HIV Infections | Phase 4 | Status: RECRUITING